Authier F, Chauvet G
Institut National de la Santé et de la Recherche Médicale U510, Faculté de Pharmacie Paris XI, 5 rue Jean-Baptiste Clément, 92296, Châtenay-Malabry, France.
FEBS Lett. 1999 Nov 12;461(1-2):25-31. doi: 10.1016/s0014-5793(99)01413-1.
We have studied the endosome-lysosome transfer of internalized epidermal growth factor receptor (EGFR) complexes in a cell-free system from rat liver. Analytical subfractionation of a postmitochondrial supernatant fraction showed that a pulse of internalized [(125)I]EGF was largely associated with a light endosomal fraction devoid of lysosomal markers. After an additional 30 min incubation in vitro in the presence of an ATP-regenerating system, the amount of [(125)I]EGF in this compartment decreased by 39%, with an increase in [(125)I]EGF in lysosomes. No transfer of [(125)I]EGF to the cytosol was detected. To assess the fate of the internalized EGFR protein over the time course of the endo-lysosomal transfer of the ligand, the effect of a saturating dose of native EGF on subsequent lysosomal targeting of the EGFR was evaluated by immunoblotting. A massive translocation of the EGFR to the endosomal compartment was observed in response to ligand injection coincident with its tyrosine phosphorylation and receptor recruitment of the tyrosine-phosphorylated adaptor protein Shc. During cell-free endosome-lysosome fusion, a time-dependent increase in the content of the EGFR and the two 55- and 46-kDa Shc isoforms was observed in lysosomal fractions with a time course superimposable with the lysosomal transfer of the ligand; no transfer of the 66-kDa Shc isoform was detected. The relationship between EGFR tyrosine kinase activity and EGFR sorting in endosomes investigated by immunoblot studies with anti-phosphotyrosine antibodies revealed that endosomal dephosphorylation of EGFR and Shc preceded lysosomal transfer. These results support the view that a lysosomal targeting machinery distinct from the endosomal receptor kinase activity, such as the recruitment of the signaling molecule Shc, may regulate this sorting event in the endosome.
我们在大鼠肝脏的无细胞体系中研究了内化的表皮生长因子受体(EGFR)复合物的内体 - 溶酶体转运过程。线粒体后上清组分的分析性亚分级分离显示,内化的[(125)I]表皮生长因子(EGF)脉冲主要与不含溶酶体标志物的轻型内体组分相关。在ATP再生系统存在下于体外再孵育30分钟后,该组分中[(125)I]EGF的量减少了39%,而溶酶体中[(125)I]EGF的量增加。未检测到[(125)I]EGF向胞质溶胶的转运。为了评估在配体内体 - 溶酶体转运过程中内化的EGFR蛋白的命运,通过免疫印迹评估了饱和剂量的天然EGF对EGFR随后溶酶体靶向的影响。观察到,响应配体注射,EGFR大量转运至内体区室,同时其酪氨酸磷酸化以及酪氨酸磷酸化衔接蛋白Shc的受体募集。在无细胞内体 - 溶酶体融合过程中,溶酶体组分中EGFR以及两种55 kDa和46 kDa的Shc异构体的含量随时间增加,其时间进程与配体的溶酶体转运重叠;未检测到66 kDa的Shc异构体的转运。用抗磷酸酪氨酸抗体进行免疫印迹研究,对内体中EGFR酪氨酸激酶活性与EGFR分选之间的关系进行研究,结果显示,EGFR和Shc的内体去磷酸化先于溶酶体转运。这些结果支持以下观点:一种不同于内体受体激酶活性的溶酶体靶向机制,例如信号分子Shc的募集,可能调节内体中的这种分选事件。